PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 6 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 6 months ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 7 months ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year 7 months ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year 8 months ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year 8 months ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 8 months ago EQS-Adhoc: BB Biotech AG publishes its 2024 annual report BB Biotech AG publishes its 2024 annual report, revealing financial performance and proposed dividend. Report includes biotech sector overview and investment details Biotechnology Investment Dividend BB Biotech AG 2024 Annual Report
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 8 months ago Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics BB Biotech's 2024 Annual Report highlights the company's strategic positioning for sector recovery amid shifting market dynamics, including key milestones and financial results Annual Report Investment Performance Sector Recovery Market Dynamics BB Biotech
BRIEF published on 01/24/2025 at 07:05, 1 year 9 months ago BB Biotech: 2024 Results and Dividend Proposal Overview Dividend Proposal Biotech Sector BB Biotech Investor Sentiment 2024 Results
BRIEF published on 01/24/2025 at 07:05, 1 year 9 months ago BB Biotech AG Reports Profit in 2024 Fiscal Year Financial Results Investment Performance BB Biotech AG 2024 Fiscal Profit Drug Developers
Published on 11/06/2026 at 13:00, 7 hours 37 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 8 hours 7 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 8 hours 7 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 15 hours 22 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 20:15, 22 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 hour 22 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 hour 37 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 2 hours 5 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 2 hours 37 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 2 hours 37 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 2 hours 43 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 3 hours 2 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
